MarginsXMarginsX
Home › Markets › Health Care › CVKD

Cadrenal Therapeutics Inc. (CVKD)

CVKD trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.40
-7.28% on the day
Market cap
$5.0M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerCVKD on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2023
SEC CIK0001937993
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Warning signs

Cash runway
2.8 months
$2.4M cash at June 30, 2026
Share count, 1 year
+74.3%
2025-08-11 to 2026-08-13 · +310.9% over 3 years
Going-concern doubt
Yes
10-Q filed August 13, 2026
Insider net buying, 12 months
-$687K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern for at least one year from the date the accompanying financial statements are issued."
10-Q 2026-08-13
Cash and burn$2.4M cash; operating cash flow -$2.5M a quarter.Report 2026-06-30
Shares outstanding3,567,592 (2026-08-13); 2,046,854 a year earlier; 13,022,754 three years earlier. 3y figure adjusted for split (1-for-15 overall).Cover page 2026-08-13
Reverse splits, 3 years1; latest 1-for-15 on 2024-08-20Source 2024-08-20
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 5 424B5 takedowns, 4 at the marketLatest 2025-12-23
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorWithumSmith+Brown, PC, East Brunswick, New Jersey, United StatesPCAOB Form AP 2026-04-02
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $687K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$3.3M-$2.2M$2.4MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2026
2026-03-31
Not filed-$2.5M-$3.0M$2.3MNo debt tagsNeeds four quarters10-Q 2026-05-07
Q4 2025
2025-12-31
Not filed-$3.0M-$2.6M$4.0MNo debt tagsNeeds four quarters10-K 2026-03-31
Q3 2025
2025-09-30
Not filed-$2.7M-$2.4M$3.9MNo debt tagsNeeds four quarters10-Q 2025-11-10
Q2 2025
2025-06-30
Not filed-$3.7M-$3.0M$5.6MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2025
2025-03-31
Not filed-$3.8M-$4.6M$7.3MNo debt tagsNeeds four quarters10-Q 2026-05-07
Q4 2024
2024-12-31
Not filed-$4.2M-$1.8M$10.0MNo debt tagsNeeds four quarters10-K 2026-03-31
Q3 2024
2024-09-30
Not filed-$2.4M-$2.2M$4.4MNo debt tagsNeeds four quarters10-Q 2025-11-10

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B32026-07-20
Latest annual report
ANNUAL REPORT
10-K2026-03-31
Latest quarterly / interim
QUARTERLY REPORT
10-Q2026-11-16
Latest current report
CURRENT REPORT
8-K2026-10-07
Latest proxy
DEFINITIVE ADDITIONAL MATERIALS
DEFA14A2026-08-03

Source: SEC EDGAR submissions feed, 278 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+54.1%
1 month+51.5%
3 months-18.8%
Year to date-77.7%
1 year-87.0%
From 52-week high-87.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
SCNXScienture Holdings Inc.$2.99+3.10%$4.9M
CNSPCNS Pharmaceuticals Inc.$3.48+20.42%$5.1M
PULMPulmatrix Inc.$1.33+2.31%$4.9M
JAGXJaguar Health Inc.$0.3864-7.74%$5.2M
PCSAProcessa Pharmaceuticals Inc.$1.72-7.53%$4.8M
CANFCan-Fite Biopharma Ltd$1.56+9.86%$4.7M
SKYESkye Bioscience Inc.$1.06-2.29%$4.7M
NCNANuCana plc American Depositary Share$0.8631-7.46%$4.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier